US Bancorp
ACH

US Bancorp’s Accendra Health ACH Stock Holding History

US Bancorp’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,000
Closed -$6.84K – 4297
2026
Q1 		$6.84K Sell
3,000
-34
-1% -$78 ﹤0.01% 3480
2025
Q4 		$8.49K Sell
3,034
-1,668
-35% -$5.96K ﹤0.01% 3386
2025
Q3 		$22.6K Sell
4,702
-1,013
-18% -$6.45K ﹤0.01% 3023
2025
Q2 		$52K Buy
5,715
+4,440
+348% +$32.7K ﹤0.01% 2767
2025
Q1 		$11.5K Buy
1,275
+1,170
+1,114% +$12.4K ﹤0.01% 3389
2024
Q4 		$1.37K Hold
105
– – ﹤0.01% 3919
2024
Q3 		$1.65K Sell
105
-605
-85% -$9.16K ﹤0.01% 3826
2024
Q2 		$9.59K Sell
710
-115
-14% -$2.35K ﹤0.01% 3318
2024
Q1 		$22.9K Sell
825
-141
-15% -$3.13K ﹤0.01% 3034
2023
Q4 		$18.6K Buy
966
+160
+20% +$2.9K ﹤0.01% 3089
2023
Q3 		$13K Sell
806
-807
-50% -$14.3K ﹤0.01% 3069
2023
Q2 		$30.7K Sell
1,613
-615
-28% -$11K ﹤0.01% 2755
2023
Q1 		$32.4K Buy
2,228
+4
+0.2% +$72 ﹤0.01% 2737
2022
Q4 		$43.4K Buy
2,224
+615
+38% +$12K ﹤0.01% 2610
2022
Q3 		$39K Buy
1,609
+68
+4% +$2.1K ﹤0.01% 2686
2022
Q2 		$48K Buy
1,541
+396
+35% +$14.3K ﹤0.01% 2611
2022
Q1 		$51K Buy
1,145
+461
+67% +$19.8K ﹤0.01% 2619
2021
Q4 		$30K Buy
684
+226
+49% +$8.86K ﹤0.01% 2903
2021
Q3 		$14K Sell
458
-109
-19% -$4.29K ﹤0.01% 3303
2021
Q2 		$24K Buy
567
+60
+12% +$2.33K ﹤0.01% 3045
2021
Q1 		$19K Buy
507
+179
+55% +$5.6K ﹤0.01% 3050
2020
Q4 		$9K Hold
328
– – ﹤0.01% 3228
2020
Q3 		$8K Hold
328
– – ﹤0.01% 3161
2020
Q2 		$2K Hold
328
– – ﹤0.01% 3525
2020
Q1 		$3K Sell
328
-1,506
-82% -$9.09K ﹤0.01% 3385
2019
Q4 		$9K Sell
1,834
-1,200
-40% -$7.71K ﹤0.01% 3141
2019
Q3 		$18K Sell
3,034
-166
-5% -$744 ﹤0.01% 2885
2019
Q2 		$10K Sell
3,200
-1,410
-31% -$4.81K ﹤0.01% 3105
2019
Q1 		$19K Sell
4,610
-1,066
-19% -$6.74K ﹤0.01% 2878
2018
Q4 		$36K Sell
5,676
-1,090
-16% -$11.3K ﹤0.01% 2590
2018
Q3 		$112K Sell
6,766
-150
-2% -$2.55K ﹤0.01% 2167
2018
Q2 		$116K Buy
6,916
+506
+8% +$8.19K ﹤0.01% 2158
2018
Q1 		$100K Sell
6,410
-957
-13% -$17.1K ﹤0.01% 2244
2017
Q4 		$139K Sell
7,367
-1,120
-13% -$24.8K ﹤0.01% 2082
2017
Q3 		$248K Sell
8,487
-256
-3% -$7.56K ﹤0.01% 1759
2017
Q2 		$281K Sell
8,743
-354
-4% -$11.6K ﹤0.01% 1676
2017
Q1 		$315K Buy
9,097
+342
+4% +$12.2K ﹤0.01% 1596
2016
Q4 		$309K Sell
8,755
-58
-0.7% -$1.96K ﹤0.01% 1590
2016
Q3 		$306K Sell
8,813
-360
-4% -$12.6K ﹤0.01% 1559
2016
Q2 		$343K Sell
9,173
-3,825
-29% -$144K ﹤0.01% 1464
2016
Q1 		$526K Sell
12,998
-636
-5% -$23.7K ﹤0.01% 1270
2015
Q4 		$490K Buy
13,634
+567
+4% +$20.5K ﹤0.01% 1306
2015
Q3 		$417K Buy
13,067
+909
+7% +$30.9K ﹤0.01% 1375
2015
Q2 		$414K Sell
12,158
-3,123
-20% -$105K ﹤0.01% 1439
2015
Q1 		$517K Sell
15,281
-6,687
-30% -$233K ﹤0.01% 1335
2014
Q4 		$771K Buy
21,968
+2,430
+12% +$81.8K ﹤0.01% 1126
2014
Q3 		$640K Buy
19,538
+2,047
+12% +$69.7K ﹤0.01% 1180
2014
Q2 		$594K Buy
17,491
+2,575
+17% +$88.2K ﹤0.01% 1251
2014
Q1 		$522K Buy
14,916
+118
+0.8% +$4.16K ﹤0.01% 1313
2013
Q4 		$541K Buy
14,798
+1,525
+11% +$56K ﹤0.01% 1262
2013
Q3 		$459K Buy
13,273
+216
+2% +$7.56K ﹤0.01% 1288
2013
Q2 		$442K Buy
+13,057
New +$433K ﹤0.01% 1235

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

US Bancorp's ACH Position: Q2 2026 in Review

US Bancorp sold out of Accendra Health (ACH) in Q2 2026, closing a stake of 3,000 shares — an estimated $6.84K sold.

US Bancorp first reported a position in ACH in Q2 2013 and held it in 52 quarters. The position peaked at $771K in Q4 2014. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • US Bancorp reported no remaining Accendra Health position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 3,000 Accendra Health shares in Q2 2026, an estimated $6.84K.
  • US Bancorp first reported a position in Accendra Health in Q2 2013 and held it in 52 quarters.
  • US Bancorp's Accendra Health position peaked at $771K in Q4 2014.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.